Quadrant Capital Group LLC Provention Bio, Inc. Transaction History

Quadrant Capital Group LLC

  • $1.42 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023
BUY
$6.7 - $24.21 $100 - $363
15 New
15 $0
Q2 2022

Aug 09, 2022
SELL
$3.65 - $7.3 $536 - $1,073
-147 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$5.66 - $8.33 $707 - $1,041
125 Added 568.18%
147 $1,000
Q2 2021

Aug 09, 2021
BUY
$6.71 - $11.04 $147 - $242
22 New
22 $0

Others Institutions Holding PRVB

# of Institutions
1
Shares Held
170K
Call Options Held
0
Put Options Held
0
View Full List

About Provention Bio, Inc.

PRVB Quotes by TradingView
  • Ticker PRVB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 81,549,904
  • Description
  • Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...
More about PRVB
Track This Portfolio

Track Quadrant Capital Group LLC Portfolio

Follow Quadrant Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email